ULURU Inc. logo — ULURU Inc. - Advancing Topical Delivery

ULURU Inc.

ULURU Inc. - Advancing Topical Delivery

Founded 1987 United States Addison, United States 26 employees IPO Total: $7.75M

General Information

Company Name ULURU Inc.
Founded Year 1987
Location United States Addison, United States +1
Employees 26
Funding Stage IPO
Social

Get notified when ULURU Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ULURU Inc.

ULURU Inc., founded in 1987 and headquartered in the United States, is a specialty pharmaceutical company that focuses on developing wound management and oral care products. The company is known for its innovative Nanoflex™ Aggregate technology and OraDisc™ transmucosal delivery system, aiming to enhance clinical outcomes through controlled delivery.

ULURU Inc. recently received a $2.22M post-IPO equity investment as of 18 September 2023. This funding suggests a continued belief in the company's growth potential and innovative processes within the biotech sector. With its long-standing presence since 1987, ULURU Inc. operates within a niche market, leveraging its proprietary technologies to stand out in the pharmaceutical industry.

The focus on improving patient outcomes positions ULURU Inc. as a promising player for investors interested in companies that blend pharmaceutical innovation with practical consumer applications.

Taxonomy: specialty pharmaceuticals, wound management, oral care products, Nanoflex Aggregate technology, OraDisc transmucosal delivery, Altrazeal, mucoadhesive film products, Nanoflex technology, patented drug delivery, oral conditions treatment, transforming powder dressing, canker sores treatment, mucoadhesive disc products, wound care innovations

Services & Products

Patented Powder Dressing
Wound Protection and Healing
Long-term Wearable Wound Dressing

Target Customers

Hospitals Clinics Military Medical Facilities Patients with Chronic Wounds

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Post Ipo Equity •••••• - 01 Sep 2023
Post Ipo Equity •••••• - 01 Nov 2019
Post Ipo Equity •••••• - 01 Apr 2016
Post Ipo Debt •••••• - 01 Apr 2015
Post Ipo Debt •••••• - 01 Mar 2014

View All 8 Funding Rounds

ULURU Inc. Alternatives & Competitors

View All Alternatives
ULURU Inc. vs

Develop mucosal adhesives for trans-mucosal drug delivery and wet tissue care product.

2 employees
ULURU Inc. vs
Medice UK Ltd
Medice UK Ltd United Kingdom

An independent, family owned pharmaceutical company, founded and managed by medical professionals to...

13 employees
Health Care, Manufacturing
ULURU Inc. vs

Advanced Materials for Soft Tissue Repair and Regeneration

Convertible Note
38 employees
Biotechnology, Health Care

FAQ About ULURU Inc.

ULURU Inc. - Advancing Topical Delivery
ULURU Inc. was founded in 1987.
ULURU Inc. is headquartered in Addison, United States.
ULURU Inc. has approximately 26 employees.
ULURU Inc. has completed 8 funding rounds, raising a total of $7.75M. The latest funding stage is IPO.
ULURU Inc. offers: Patented Powder Dressing, Wound Protection and Healing, Long-term Wearable Wound Dressing.
Top alternatives and competitors to ULURU Inc. include MoleculeX Co., Ltd., Medice UK Ltd, Imbed Biosciences Inc., Vectura Group, Innoture. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ULURU Inc. and MoleculeX Co., Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ULURU Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes